Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 June 2009, doi:10.1136/bmj.b2598
Cite this as: BMJ 2009;338:b2598
| The first 100% of the full text of this article appears below. |
Are there any outcome or tolerability data from large trials of antihypertensive agents in normotensive people? If not, to adopt the recommendations of Law and colleagues means the classic error of generalising from one population to another—in this case, from the hypertensive to the normotensive population.1
Furthermore, patients prescribed antihypertensive drugs are likely to feel medicalised, and a substantial number are likely to interpret any number of temporally related physical changes as being due to the drug, whether physiologically plausible (dizziness, cough, erectile dysfunction, oedema, polyuria, rash) or not (any primary care doctor can provide multiple examples). They will return for changes in treatment, reassurance, and further evaluation, diverting resources which might be better used elsewhere.
Cite this as: BMJ 2009;338:b2598
Anthony N Glaser, assistant professor of family medicine1
1 Medical University of South Carolina, Flowertown University Family Medicine, Summerville, SC 29483, USA
glaser@musc.edu